MedPath

Identification of response of the nasal flora to Nasyakarma in sinusitis.

Phase 3
Conditions
Health Condition 1: J328- Other chronic sinusitis
Registration Number
CTRI/2022/07/043644
Lead Sponsor
Dr Shruthi Sreedharan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Nasya Arha

2.Age - Between 18 - 50 years, irrespective of gender.

3.Subjects presenting with two or more symptoms of (for more than 12 weeks)

Nasal congestion

Facial pain/pressure

Anterior or posterior drainage

Reduced or absent sense of smell

Exclusion Criteria

1.Nasya Anarha

2.Subjects under antimicrobial therapy, undergone vaccination recently.

3.Subjects suffering from long standing debilitating illness.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the changes in the nasal microbiota after Nasya Karma in CRS, by microbial culture of nasal swab sample of both the nostrilsTimepoint: The day before starting Nasyam, then on the 8th day the nasal swab sample culture would be analysed.
Secondary Outcome Measures
NameTimeMethod
To assess the composition and load of the nasal microbiota before and after the Nasya Karma by analysis of the microbial culture of nasal swab sample of both nostrils. <br/ ><br>To propose a possible mechanism of action of the Nasya Karma on the nasal microbiome in CRS. <br/ ><br>Timepoint: Zeroth day, before starting the procedure and on the eighth day after the procedure
© Copyright 2025. All Rights Reserved by MedPath